CSF1R and neoplasm: In line with the observation that RTK are among the most dynamic targets contributing to tumor heterogeneity, as shown by single cell RNA-seq studies [66], here we provide evidence for the existence of cisplatin-resistant, lung cancer cell subpopulations expressing the Colony Stimulating Factor Receptor −1 (CSF-1R).